Potential clinical drugs as covalent inhibitors of the priming proteases of the spike protein of SARS-CoV-2-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Potential clinical drugs as covalent inhibitors of the priming proteases of the spike protein of SARS-CoV-2

Published:2020 Issue: Volume:18 Page:2200-2208
ISSN:2001-0370
Container-title:Computational and Structural Biotechnology Journal
language:en
Short-container-title:Computational and Structural Biotechnology Journal

Author:

Li Qizhang,Wang Zhiying,Zheng Qiang,Liu Sen^ORCID

Funder

Department of Science and Technology, Hubei Provincial People's Government

National Natural Science Foundation of China

Wuhan Municipal Science and Technology Bureau

Publisher

Elsevier BV

Subject

Computer Science Applications,Genetics,Biochemistry,Structural Biology,Biophysics,Biotechnology

Reference41 articles.

1. Radiology perspective of Coronavirus Disease 2019 (COVID-19): lessons from severe acute respiratory syndrome and Middle East respiratory syndrome;Hosseiny;AJR Am J Roentgenol,2020

2. Rising concern on damaged testis of COVID-19 patients;Chen;Urology,2020

3. Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Di Napoli R. Features, Evaluation and Treatment Coronavirus (COVID-19) 2020.

4. Deconstructing the drug development process: the new face of innovation;Kaitin;Clin Pharmacol Ther,2010

5. A bibliometric review of drug repurposing;Baker;Drug Discovery Today,2018

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Challenges and Emerging Problems in CADD;Drug Delivery Systems Using Quantum Computing;2024-07

2. Targeting epidermal growth factor receptor signalling pathway: A promising therapeutic option for COVID‐19;Reviews in Medical Virology;2023-12-21

3. Covalent inhibitors: An ambitious approach for the discovery of newer oncotherapeutics;Drug Development Research;2023-12-06

4. Discovery of druggable potent inhibitors of serine proteases and farnesoid X receptor by ligand-based virtual screening to obstruct SARS-CoV-2;International Journal of Biological Macromolecules;2023-12

5. Cathepsins and SARS‐CoV‐2 infection: From pathogenic factors to potential therapeutic targets;British Journal of Pharmacology;2023-08-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3